Rozlytrek capsules 200mg, with the ingredient Entrectinib, are produced by Chugai Pharmaceutical. This medication (YJ code: 4291061M2021, 200mg x 1 capsule) is a targeted therapy indicated for adult and pediatric patients with solid tumors that have an NTRK gene fusion, or adult patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC).
Rozlytrek capsules 200mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →